Anika Therapeutics Files 8-K on Financials
Ticker: ANIK · Form: 8-K · Filed: Mar 12, 2025 · CIK: 898437
| Field | Detail |
|---|---|
| Company | Anika Therapeutics, Inc. (ANIK) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Anika Therapeutics dropped an 8-K on March 12th covering financials. Check it out.
AI Summary
Anika Therapeutics, Inc. filed an 8-K on March 12, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and headquartered in Bedford, Massachusetts.
Why It Matters
This 8-K filing provides investors with crucial updates on Anika Therapeutics' financial performance and condition, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Anika Therapeutics, Inc. (company) — Registrant
- March 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Bedford, Massachusetts (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed?
The filing was made on March 12, 2025.
What is the principal business address of Anika Therapeutics, Inc.?
The principal executive offices are located at 32 Wiggins Avenue, Bedford, Massachusetts 01730.
Under which section of the Securities Exchange Act is this report filed?
This is a Current Report filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Anika Therapeutics, Inc.?
The Standard Industrial Classification code is 3841, for SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding Anika Therapeutics, Inc. (ANIK).